CORONARY ANGIOGRAPHIC CHARACTERISTICS IN JAPANESE PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

被引:19
|
作者
GENDA, A [1 ]
NAKAYAMA, A [1 ]
SHIMIZU, M [1 ]
NUNODA, S [1 ]
SUGIHARA, N [1 ]
SUEMATZU, T [1 ]
KITA, Y [1 ]
YOSHIMURA, A [1 ]
KOIZUMI, J [1 ]
MABUCHI, H [1 ]
TAKEDA, R [1 ]
机构
[1] KANAZAWA UNIV,SCH MED,CTR HLTH CARE,KANAZAWA,ISHIKAWA 920,JAPAN
关键词
D O I
10.1016/0021-9150(87)90176-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:29 / 36
页数:8
相关论文
共 50 条
  • [21] Heterozygous familial hypercholesterolemia
    Ozcan, Ozgr Ulas
    Gulec, Sadi
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2014, 42 : 10 - 18
  • [22] Heterozygous Familial Hypercholesterolemia
    Onorato, Angela
    Sturm, Amy C.
    CIRCULATION, 2016, 133 (14) : E587 - E589
  • [23] Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
    Santos, Raul D.
    Wiegman, Albert
    Caprio, Sonia
    Cariou, Bertrand
    Averna, Maurizio
    Poulouin, Yann
    Scemama, Michel
    Manvelian, Garen
    Garon, Genevieve
    Daniels, Stephen
    JAMA PEDIATRICS, 2024, 178 (03) : 283 - 293
  • [24] Rosuvastatin produces substantial improvements in the lipid profile of Japanese patients with heterozygous familial hypercholesterolemia
    Mabuchi, H
    Nohara, A
    Higashikata, T
    Ueda, K
    Bujo, H
    Matsushima, T
    Ikeda, Y
    Ni, M
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 133 - 133
  • [25] Lipoprotein(a) metabolism in patients with heterozygous familial hypercholesterolemia
    Parhofer, KG
    Ritter, MM
    Geiss, C
    Schwandt, P
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 146 - 146
  • [26] Colesevelam: In pediatric patients with heterozygous familial hypercholesterolemia
    Perry C.M.
    Pediatric Drugs, 2010, 12 (2) : 133 - 140
  • [27] Efficacy and safety of pravastatin 40 mg day in Japanese patients with heterozygous familial hypercholesterolemia
    Mabuchi, H
    Matsuzawa, Y
    Saito, Y
    Gunji, A
    ATHEROSCLEROSIS, 1999, 144 : 194 - 194
  • [28] THE MIDBAND LIPOPROTEIN IS A CORONARY RISK FACTOR IN JAPANESE PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    TASHIRO, J
    NISHIDE, T
    SHINOMIYA, M
    SHIRAI, K
    SAITO, Y
    YOSHIDA, S
    YAMASHITA, M
    OHSHIMA, H
    MURAYAMA, H
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1993, 53 (04): : 335 - 338
  • [29] IMPACT OF CORONARY ARTERY CALCIUM ON THE PROGNOSIS OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Tada, H.
    Nohara, A.
    Kawashiri, M. -A.
    Takamura, M.
    ATHEROSCLEROSIS, 2023, 379
  • [30] Coronary Perivascular Fat Attenuation Index in Heterozygous Familial Hypercholesterolemia
    Miname, Marcio H.
    Bercht, Andrea M.
    Morais, Thamara
    Assuncao, Antonildes, Jr.
    Santos, Raul D.
    Nomura, Cesar Higa
    CIRCULATION, 2019, 140